APGE
Price
$55.15
Change
+$1.75 (+3.28%)
Updated
Oct 17 closing price
Capitalization
3.73B
31 days until earnings call
RCUS
Price
$16.47
Change
-$0.13 (-0.78%)
Updated
Oct 17 closing price
Capitalization
1.75B
24 days until earnings call
Interact to see
Advertisement

APGE vs RCUS

Header iconAPGE vs RCUS Comparison
Open Charts APGE vs RCUSBanner chart's image
Apogee Therapeutics
Price$55.15
Change+$1.75 (+3.28%)
Volume$1.04M
Capitalization3.73B
Arcus Biosciences
Price$16.47
Change-$0.13 (-0.78%)
Volume$1.11M
Capitalization1.75B
APGE vs RCUS Comparison Chart in %
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. RCUS commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and RCUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (APGE: $53.40 vs. RCUS: $16.60)
Brand notoriety: APGE and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 142% vs. RCUS: 182%
Market capitalization -- APGE: $3.73B vs. RCUS: $1.75B
APGE [@Biotechnology] is valued at $3.73B. RCUS’s [@Biotechnology] market capitalization is $1.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while RCUS’s TA Score has 3 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 4 bearish.
  • RCUS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, APGE is a better buy in the short-term than RCUS.

Price Growth

APGE (@Biotechnology) experienced а +0.36% price change this week, while RCUS (@Biotechnology) price change was +9.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +16.02%, and the average quarterly price growth was +79.42%.

Reported Earning Dates

APGE is expected to report earnings on Nov 18, 2025.

RCUS is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($3.73B) has a higher market cap than RCUS($1.75B). APGE YTD gains are higher at: 21.744 vs. RCUS (10.611). APGE (-270.1M) and RCUS (-282M) have comparable annual earnings (EBITDA) . RCUS has more cash in the bank: 911M vs. APGE (505M). APGE has less debt than RCUS: APGE (10.8M) vs RCUS (109M). RCUS has higher revenues than APGE: RCUS (262M) vs APGE (0).
APGERCUSAPGE / RCUS
Capitalization3.73B1.75B213%
EBITDA-270.1M-282M96%
Gain YTD21.74410.611205%
P/E RatioN/AN/A-
Revenue0262M-
Total Cash505M911M55%
Total Debt10.8M109M10%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGERCUS
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
72%
Bearish Trend 15 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMVQX36.620.17
+0.47%
JPMorgan Mid Cap Value R4
PGEMX27.820.09
+0.32%
George Putnam Balanced M
GIXIX10.73N/A
N/A
Nationwide International Index R6
OFSAX21.59-0.01
-0.05%
Olstein Strategic Opportunities A
CIGCX20.06-0.19
-0.94%
Calamos International Growth C

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+3.28%
SYRE - APGE
58%
Loosely correlated
+1.03%
CGON - APGE
52%
Loosely correlated
-0.93%
NUVL - APGE
50%
Loosely correlated
+2.32%
IRON - APGE
50%
Loosely correlated
+20.95%
DYN - APGE
50%
Loosely correlated
-0.24%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-0.78%
XNCR - RCUS
54%
Loosely correlated
-1.20%
IDYA - RCUS
49%
Loosely correlated
+5.67%
IMNM - RCUS
48%
Loosely correlated
-4.97%
APGE - RCUS
48%
Loosely correlated
+3.28%
MNMD - RCUS
47%
Loosely correlated
+14.61%
More